Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.
Walker
M C
MC
Institute of Neurology, National Hospital for Neurology and Neurosurgery, London.
Li
L M
LM
Sander
J W
JW
D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004827:Epilepsy / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D000077213:Lamotrigine; D015996:Survival Rate; D016896:Treatment Outcome; D014227:Triazines / Q000009:adverse effects / Q000627:therapeutic use*; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D014227:Triazines; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin; D000077213:Lamotrigine